MBX Biosciences: Funding, Investors & Team (Oct 2026)
MBX Biosciences is a biotechnology company that specializes in creating therapies for rare endocrine conditions that currently lack effective treatment options. The company is dedicated to advancing innovative endocrine treatments through research, development, and bringing these therapies to market.
MBX Biosciences has raised $213M across 3 funding rounds on record, the most recent a Series C of $63.5M announced in Aug 2024.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MBX Biosciences Company Profile and Key Stats
Latest funding round on record: Aug 2024.
MBX Biosciences Funding Rounds
MBX Biosciences raised $34.6M in an undisclosed round announced in Jul 2020.
2.3 years later, a Series B of $115M was announced in Nov 2022.
1.8 years later, a Series C of $63.5M was announced in Aug 2024.
MBX Biosciences Founders and Leadership Team
Contact details for the MBX Biosciences team: 1 of 3 have an email address on file.
Start 14-day free trial →MBX Biosciences Funding Compared to Other Biotechnology Startups
MBX Biosciences' latest round of $63.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MBX Biosciences in Biotechnology and Carmel
Companies Similar to MBX Biosciences
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
MBX Biosciences Funding FAQs
What does MBX Biosciences do?
MBX Biosciences is a biotechnology company that specializes in creating therapies for rare endocrine conditions that currently lack effective treatment options. The company is dedicated to advancing innovative endocrine treatments through research, development, and bringing these therapies to market.
How much funding has MBX Biosciences raised?
MBX Biosciences has raised $213M across 3 rounds on record. The most recent is a Series C of $63.5M announced in Aug 2024.
When did MBX Biosciences last raise funding?
MBX Biosciences' most recent funding round on record is a Series C of $63.5M, announced in Aug 2024.
Who founded MBX Biosciences?
FundedIQ lists Tim Knickerbocker (Founder) at MBX Biosciences.
Who is the CEO of MBX Biosciences?
Kent Hawryluk is listed as CEO at MBX Biosciences.
Where is MBX Biosciences headquartered?
MBX Biosciences is based in Carmel, Indiana, United States.
How many employees does MBX Biosciences have?
MBX Biosciences is in the 11-50 employee band.
How does MBX Biosciences' funding compare to other Biotechnology startups?
MBX Biosciences' latest round of $63.5M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's MBX Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MBX Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.